Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» focal segmental glomerulosclerosis
focal segmental glomerulosclerosis
Travere trips up but others are following in rare kidney disease
EP Vantage
Fri, 05/5/23 - 10:07 am
Travere Therapeutics
Filspari
focal segmental glomerulosclerosis
Travere’s FSGS therapy trial fails to meet primary efficacy endpoint
Clinical Trials Arena
Tue, 05/2/23 - 11:30 am
Travere Therapeutics
sparsentan
focal segmental glomerulosclerosis
clinical trials
Vertex, needing research spark, finds promising results in small study of kidney disease drug
BioPharma Dive
Wed, 12/1/21 - 10:24 am
Vertex Pharmaceuticals
kidney disease
clinical trials
focal segmental glomerulosclerosis
Retrophin (With Help From Martin Shkreli) Advances Drug for Rare Kidney Disease
TheStreet.com
Wed, 09/7/16 - 10:04 am
Retrophin
Martin Shkreli
sparsentan
kidney disease
focal segmental glomerulosclerosis